Title:
AQUEOUS SUSPENSION COMPOSITION CONTAINING SIROLIMUS OR SALT THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/132565
Kind Code:
A1
Abstract:
The purpose of the present invention is to provide an aqueous suspension composition that contains poorly soluble sirolimus and that is for use in ophthalmology, especially in topical administration of less-invasive eye drops or the like. This aqueous suspension composition is for use in ophthalmology, contains a surfactant and sirolimus or a salt thereof, and has a pH of 4-6.
Inventors:
FUJISAWA TOYOMI (JP)
AKUTAGAWA AYAKA (JP)
AKUTAGAWA AYAKA (JP)
Application Number:
PCT/JP2020/048738
Publication Date:
July 01, 2021
Filing Date:
December 25, 2020
Export Citation:
Assignee:
SANTEN PHARMACEUTICAL CO LTD (JP)
International Classes:
A61K31/436; A61K9/10; A61K47/26; A61K47/38; A61P27/02
Domestic Patent References:
| WO2014142146A1 | 2014-09-18 |
Foreign References:
| CN106420607A | 2017-02-22 | |||
| CN107334734A | 2017-11-10 | |||
| JP2010536797A | 2010-12-02 | |||
| JPH05194212A | 1993-08-03 | |||
| JP2010540682A | 2010-12-24 |
Other References:
See also references of EP 4082544A4
Attorney, Agent or Firm:
TSUKUNI & ASSOCIATES (JP)
Download PDF: